2351 related articles for article (PubMed ID: 11032018)
21. Stem cell factor augments Fc epsilon RI-mediated TNF-alpha production and stimulates MAP kinases via a different pathway in MC/9 mast cells.
Ishizuka T; Kawasome H; Terada N; Takeda K; Gerwins P; Keller GM; Johnson GL; Gelfand EW
J Immunol; 1998 Oct; 161(7):3624-30. PubMed ID: 9759885
[TBL] [Abstract][Full Text] [Related]
22. Transforming growth factor-beta1 activates interleukin-6 expression in prostate cancer cells through the synergistic collaboration of the Smad2, p38-NF-kappaB, JNK, and Ras signaling pathways.
Park JI; Lee MG; Cho K; Park BJ; Chae KS; Byun DS; Ryu BK; Park YK; Chi SG
Oncogene; 2003 Jul; 22(28):4314-32. PubMed ID: 12853969
[TBL] [Abstract][Full Text] [Related]
23. A dominant role for the c-Jun NH2-terminal kinase in oncogenic ras-induced morphologic transformation of human lung carcinoma cells.
Xiao L; Lang W
Cancer Res; 2000 Jan; 60(2):400-8. PubMed ID: 10667594
[TBL] [Abstract][Full Text] [Related]
24. Effector domain mutants of Rho dissociate cytoskeletal changes from nuclear signaling and cellular transformation.
Zohar M; Teramoto H; Katz BZ; Yamada KM; Gutkind JS
Oncogene; 1998 Aug; 17(8):991-8. PubMed ID: 9747878
[TBL] [Abstract][Full Text] [Related]
25. Opposite effects of Ha-Ras and Ki-Ras on radiation-induced apoptosis via differential activation of PI3K/Akt and Rac/p38 mitogen-activated protein kinase signaling pathways.
Choi JA; Park MT; Kang CM; Um HD; Bae S; Lee KH; Kim TH; Kim JH; Cho CK; Lee YS; Chung HY; Lee SJ
Oncogene; 2004 Jan; 23(1):9-20. PubMed ID: 14712206
[TBL] [Abstract][Full Text] [Related]
26. Ras-interacting domain of Ral GDP dissociation stimulator like (RGL) reverses v-Ras-induced transformation and Raf-1 activation in NIH3T3 cells.
Okazaki M; Kishida S; Murai H; Hinoi T; Kikuchi A
Cancer Res; 1996 May; 56(10):2387-92. PubMed ID: 8625316
[TBL] [Abstract][Full Text] [Related]
27. Signal transduction elements of TC21, an oncogenic member of the R-Ras subfamily of GTP-binding proteins.
Movilla N; Crespo P; Bustelo XR
Oncogene; 1999 Oct; 18(43):5860-9. PubMed ID: 10557073
[TBL] [Abstract][Full Text] [Related]
28. R-Ras induces malignant, but not morphologic, transformation of NIH3T3 cells.
Cox AD; Brtva TR; Lowe DG; Der CJ
Oncogene; 1994 Nov; 9(11):3281-8. PubMed ID: 7936652
[TBL] [Abstract][Full Text] [Related]
29. A role for Ras in v-Crk transformation.
Greulich H; Hanafusa H
Cell Growth Differ; 1996 Nov; 7(11):1443-51. PubMed ID: 8930393
[TBL] [Abstract][Full Text] [Related]
30. K-ras codon 12 mutation induces higher level of resistance to apoptosis and predisposition to anchorage-independent growth than codon 13 mutation or proto-oncogene overexpression.
Guerrero S; Casanova I; Farré L; Mazo A; Capellà G; Mangues R
Cancer Res; 2000 Dec; 60(23):6750-6. PubMed ID: 11118062
[TBL] [Abstract][Full Text] [Related]
31. Microtubule inhibitors elicit differential effects on MAP kinase (JNK, ERK, and p38) signaling pathways in human KB-3 carcinoma cells.
Stone AA; Chambers TC
Exp Cell Res; 2000 Jan; 254(1):110-9. PubMed ID: 10623471
[TBL] [Abstract][Full Text] [Related]
32. Reconstitution of signal transduction from the membrane to the nucleus in a baculovirus expression system: activation of Raf-1 leads to hypermodification of c-jun and c-fos via multiple pathways.
Agarwal S; Corbley MJ; Roberts TM
Oncogene; 1995 Aug; 11(3):427-38. PubMed ID: 7543194
[TBL] [Abstract][Full Text] [Related]
33. Tyrosine phosphorylation of Vav stimulates IL-6 production in mast cells by a Rac/c-Jun N-terminal kinase-dependent pathway.
Song JS; Haleem-Smith H; Arudchandran R; Gomez J; Scott PM; Mill JF; Tan TH; Rivera J
J Immunol; 1999 Jul; 163(2):802-10. PubMed ID: 10395673
[TBL] [Abstract][Full Text] [Related]
34. Phosphatidylinositol-3 kinase dependent pathways: the role in control of cell growth, survival, and malignant transformation.
Krasilnikov MA
Biochemistry (Mosc); 2000 Jan; 65(1):59-67. PubMed ID: 10702641
[TBL] [Abstract][Full Text] [Related]
35. Cadmium-induced hormetic effect in differentiated Caco-2 cells: ERK and p38 activation without cell proliferation stimulation.
Mantha M; Jumarie C
J Cell Physiol; 2010 Jul; 224(1):250-61. PubMed ID: 20232314
[TBL] [Abstract][Full Text] [Related]
36. Overexpression of mitogen-activated protein kinase kinase kinase reversed cAMP inhibition of NF-kappaB in T cells.
Ho HY; Lee HH; Lai MZ
Eur J Immunol; 1997 Jan; 27(1):222-6. PubMed ID: 9022022
[TBL] [Abstract][Full Text] [Related]
37. Regulation of c-myc expression by Ras/Raf signalling.
Kerkhoff E; Houben R; Löffler S; Troppmair J; Lee JE; Rapp UR
Oncogene; 1998 Jan; 16(2):211-6. PubMed ID: 9464539
[TBL] [Abstract][Full Text] [Related]
38. Rap1 mediates sustained MAP kinase activation induced by nerve growth factor.
York RD; Yao H; Dillon T; Ellig CL; Eckert SP; McCleskey EW; Stork PJ
Nature; 1998 Apr; 392(6676):622-6. PubMed ID: 9560161
[TBL] [Abstract][Full Text] [Related]
39. Comparative effects of insulin on the activation of the Raf/Mos-dependent MAP kinase cascade in vitellogenic versus postvitellogenic Xenopus oocytes.
Chesnel F; Bonnec G; Tardivel A; Boujard D
Dev Biol; 1997 Aug; 188(1):122-33. PubMed ID: 9245517
[TBL] [Abstract][Full Text] [Related]
40. The PEA3 Ets transcription factor is a downstream target of the HER2/Neu receptor tyrosine kinase.
O'Hagan RC; Hassell JA
Oncogene; 1998 Jan; 16(3):301-10. PubMed ID: 9467955
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]